# Voraxaze

NDC: 50633-210
Generic name: glucarpidase
Labeler / Manufacturer: BTG International Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20120401

FDA application: BLA125327

## Active ingredients

- GLUCARPIDASE: 1000 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50633-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50633-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaef5a6-b740-40e3-8ffe-74a75c74745c